JSS Sustainable Equity - Future Health M USD acc

Reference Data

ISIN LU2041628590
Valor Number 49478901
Bloomberg Global ID
Fund Name JSS Sustainable Equity - Future Health M USD acc
Fund Provider J. Safra Sarasin Investmentfonds AG Basel, Switzerland
Phone: +41 58 317 44 44
Web: www.jsafrasarasin.com
Fund Provider J. Safra Sarasin Investmentfonds AG
Representative in Switzerland J. Safra Sarasin Investmentfonds AG
Basel
Phone: +41 58 317 44 00
Distributor(s) Bank J. Safra Sarasin AG
Basel
Phone: +41 58 317 44 00
Asset Class Equities
EFC Category
Distribution Policy Accumulation
Home Country Luxembourg
Issuing Condition The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** The investment objective of the fund is to achieve long-term capital growth. The Reference Currency of the Sub-Fund is the US Dollar (USD).
Peculiarities

Fund Prices

Current Price * 103.38 USD 29.04.2024
Previous Price * 102.98 USD 26.04.2024
52 Week High * 110.74 USD 08.05.2023
52 Week Low * 87.01 USD 27.10.2023
NAV * 103.38 USD 29.04.2024
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 138,301,375
Unit/Share Assets *** 190,559
Trading Information SIX

Performance

YTD Performance - -
YTD Performance (in CHF) - -
1 month -0.04% 02.04.2024
29.04.2024
3 months +0.49% 29.01.2024
29.04.2024
6 months +18.43% 30.10.2023
29.04.2024
1 year -4.97% 02.05.2023
29.04.2024
2 years +3.38% 14.09.2022
29.04.2024
3 years - -
5 years - -

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

UnitedHealth Group Inc 9.27%
Eli Lilly and Co 6.74%
Sanofi SA 6.60%
Danaher Corp 6.30%
Gilead Sciences Inc 5.20%
Intuitive Surgical Inc 4.51%
Boston Scientific Corp 4.22%
Johnson & Johnson 4.17%
Novo Nordisk AS Class B 3.87%
argenx SE 3.71%
Last data update 31.03.2025

Cost / Risk

TER 0.40%
TER date 31.10.2024
Performance Fee ***
PTR
Max. Management Fee *** 0.12%
Ongoing Charges *** 0.28%
SRRI ***
SRRI date *** 30.04.2024

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)